A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
3/25/2025, 10:56 AMSummary of Bill S 1096
Bill 119 s 1096, also known as the "Preserve Access to Affordable Generics and Biosimilars Act," aims to address the issue of brand name drug companies paying generic drug companies to delay the entry of generic drugs into the market. This practice, known as "pay-for-delay," can result in higher drug prices for consumers and limit competition in the pharmaceutical industry.The bill specifically prohibits brand name drug companies from compensating generic drug companies to delay the entry of generic drugs into the market. Additionally, it also prohibits biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
By preventing these types of agreements, the bill seeks to promote competition in the pharmaceutical industry and increase access to affordable generic and biosimilar drugs for consumers. This legislation is important in ensuring that patients have access to more affordable medication options and that the market remains competitive. Overall, Bill 119 s 1096 aims to protect consumers from potentially harmful practices that can drive up drug prices and limit access to affordable medications. It is a step towards promoting a more competitive and transparent pharmaceutical industry.
Current Status of Bill S 1096
Bill S 1096 is currently in the status of Bill Introduced since March 24, 2025. Bill S 1096 was introduced during Congress 119 and was introduced to the Senate on March 24, 2025. Bill S 1096's most recent activity was Read twice and referred to the Committee on the Judiciary. as of March 24, 2025Bipartisan Support of Bill S 1096
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
8Democrat Cosponsors
5Republican Cosponsors
3Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 1096
Primary Policy Focus
Alternate Title(s) of Bill S 1096
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.Comments
Most relevant
Sponsors and Cosponsors of S 1096
Latest Bills
Full-Year Continuing Appropriations and Extensions Act, 2025
Bill HR 1968March 25, 2025
Love Lives On Act of 2025
Bill S 410March 25, 2025
Federal Prisons Accountability Act of 2025
Bill S 698March 25, 2025
A bill to establish in the Department of State the Office to Monitor and Combat Islamophobia, and for other purposes.
Bill S 805March 25, 2025
A bill to amend the Internal Revenue Code of 1986 to exclude from gross income interest received on certain loans secured by rural or agricultural real property.
Bill S 838March 25, 2025
A bill to amend the Employee Retirement Income Security Act of 1974 to provide for greater spousal protection under defined contribution plans, and for other purposes.
Bill S 988March 25, 2025
A bill to require the Federal Communications Commission to issue an order providing that a shark attack is an event for which a wireless emergency alert may be transmitted, and for other purposes.
Bill S 1003March 25, 2025
A bill to address and take action to prevent bullying and harassment of students.
Bill S 986March 25, 2025
A bill to amend title 38, United States Code, to ensure that the Secretary of Veterans Affairs repays members of the Armed Forces for certain contributions made by such members towards Post-9/11 Educational Assistance, and for other purposes.
Bill S 972March 25, 2025
A bill to apply the Medicaid asset verification program to all applicants for, and recipients of, medical assistance in all States and territories, and for other purposes.
Bill S 1082March 25, 2025